Categories
COVID-19

Gilead says remdesivir helped moderate COVID-19 patients improve

Gilead Sciences, the company behind the antiviral drug, says it will be donating 1.5 million vials to the federal government. Early results from the NIH controlled trial show patients taking remdesivir improved faster than those taking a placebo, but the full study has not been published.

  1. Gilead says remdesivir helped moderate COVID-19 patients improve